| Symbol |
Name |
|
ABAT
|
4-aminobutyrate aminotransferase
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ACKR2
|
atypical chemokine receptor 2
|
|
ACLY
|
ATP citrate lyase
|
|
ADA
|
adenosine deaminase
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AIMP2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATM
|
ATM serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
C5
|
complement component 5
|
|
C7
|
complement component 7
|
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CCK
|
cholecystokinin
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CDH13
|
cadherin 13
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CENPJ
|
centromere protein J
|
|
CEP120
|
centrosomal protein 120kDa
|
|
CFH
|
complement factor H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPSF6
|
cleavage and polyadenylation specific factor 6, 68kDa
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTSB
|
cathepsin B
|
|
CUL1
|
cullin 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DES
|
desmin
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
E2F1
|
E2F transcription factor 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
ELANE
|
elastase, neutrophil expressed
|
|
EP300
|
E1A binding protein p300
|
|
EPO
|
erythropoietin
|
|
ERO1L
|
ERO1-like (S. cerevisiae)
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXO18
|
F-box protein, helicase, 18
|
|
FCRL3
|
Fc receptor-like 3
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR1OP2
|
FGFR1 oncogene partner 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXO1
|
forkhead box O1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX7
|
glutathione peroxidase 7
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HBB
|
hemoglobin, beta
|
|
HDAC9
|
histone deacetylase 9
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IHH
|
indian hedgehog
|
|
IL10
|
interleukin 10
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL2
|
interleukin 2
|
|
IL22
|
interleukin 22
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGB1BP1
|
integrin beta 1 binding protein 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT18
|
keratin 18, type I
|
|
LAMTOR1
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1
|
|
LCN2
|
lipocalin 2
|
|
LDLRAD4
|
low density lipoprotein receptor class A domain containing 4
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LOX
|
lysyl oxidase
|
|
LTB4R
|
leukotriene B4 receptor
|
|
MAOA
|
monoamine oxidase A
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIR449A
|
microRNA 449a
|
|
MIR449B
|
microRNA 449b
|
|
MIR9-1
|
microRNA 9-1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPZ
|
myelin protein zero
|
|
MSX1
|
msh homeobox 1
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUS81
|
MUS81 structure-specific endonuclease subunit
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYLK
|
myosin light chain kinase
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NDEL1
|
nudE neurodevelopment protein 1-like 1
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NF1
|
neurofibromin 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOTCH1
|
notch 1
|
|
NPC1L1
|
NPC1-like 1
|
|
NPPA
|
natriuretic peptide A
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NUCB2
|
nucleobindin 2
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
ORM1
|
orosomucoid 1
|
|
OTUD7B
|
OTU deubiquitinase 7B
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLK4
|
polo-like kinase 4
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPM1H
|
protein phosphatase, Mg2+/Mn2+ dependent, 1H
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRSS8
|
protease, serine, 8
|
|
PSEN1
|
presenilin 1
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTX3
|
pentraxin 3, long
|
|
PYGL
|
phosphorylase, glycogen, liver
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RC3H1
|
ring finger and CCCH-type domains 1
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SESN3
|
sestrin 3
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFTPD
|
surfactant protein D
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD7
|
SMAD family member 7
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SPICE1
|
spindle and centriole associated protein 1
|
|
SQSTM1
|
sequestosome 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
|
SUMO4
|
small ubiquitin-like modifier 4
|
|
SYT11
|
synaptotagmin XI
|
|
TAC1
|
tachykinin, precursor 1
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
THBD
|
thrombomodulin
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR9
|
toll-like receptor 9
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNPO3
|
transportin 3
|
|
TP53
|
tumor protein p53
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TTC5
|
tetratricopeptide repeat domain 5
|
|
UBXN1
|
UBX domain protein 1
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UIMC1
|
ubiquitin interaction motif containing 1
|
|
VCAN
|
versican
|
|
VCP
|
valosin containing protein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VMA21
|
VMA21 vacuolar H+-ATPase homolog (S. cerevisiae)
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
